Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline Uptake

Alzheimer’s disease (AD) is thought to be a series of neuroinflammatory diseases caused by abnormal deposits of amyloid-β (Aβ) and tau protein in the brain as part of its etiology. We focused on Aβ aggregation and M1 and M2 microglial polarity in microglia to search for novel therapeutic agents. It...

Full description

Bibliographic Details
Main Authors: Eisuke Muto, Toshio Okada, Tsuyoshi Yamanaka, Hiroyuki Uchino, Masato Inazu
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/13/2/191
_version_ 1797622153411035136
author Eisuke Muto
Toshio Okada
Tsuyoshi Yamanaka
Hiroyuki Uchino
Masato Inazu
author_facet Eisuke Muto
Toshio Okada
Tsuyoshi Yamanaka
Hiroyuki Uchino
Masato Inazu
author_sort Eisuke Muto
collection DOAJ
description Alzheimer’s disease (AD) is thought to be a series of neuroinflammatory diseases caused by abnormal deposits of amyloid-β (Aβ) and tau protein in the brain as part of its etiology. We focused on Aβ aggregation and M1 and M2 microglial polarity in microglia to search for novel therapeutic agents. It has been reported that the inhibition of choline uptake via choline transporter-like protein 1 (CTL1) in microglia preferentially induces M2 microglial polarity. However, the role of the choline transport system on the regulation of microglial M1/M2 polarity in AD is not fully understood. Licochalcones (Licos) A–E, flavonoids extracted from licorice, have been reported to have immunological anti-inflammatory effects, and Lico A inhibits Aβ aggregation. In this study, we compared the efficacy of five Licos, from Lico A to E, at inhibiting Aβ1-42 aggregation. Among the five Licos, Lico E was selected to investigate the relationship between the inhibition of choline uptake and microglial M1/M2 polarization using the immortalized mouse microglial cell line SIM-A9. We newly found that Lico E inhibited choline uptake and Aβ1-42 aggregation in SIM-A9 cells in a concentration-dependent manner, suggesting that the inhibitory effect of Lico E on choline uptake is mediated by CTL1. The mRNA expression of tumor necrosis factor (TNF-α), a marker of M1 microglia, was increased by Aβ1-42, and its effect was inhibited by choline deprivation and Lico E in a concentration-dependent manner. In contrast, the mRNA expression of arginase-1 (Arg-1), a marker of M2 microglia, was increased by IL-4, and its effect was enhanced by choline deprivation and Lico E. We found that Lico E has an inhibitory effect on Aβ aggregation and promotes polarity from M1 to M2 microglia via inhibition of the CTL1 function in microglia. Thus, Lico E may become a leading compound for a novel treatment of AD.
first_indexed 2024-03-11T09:06:16Z
format Article
id doaj.art-bee769db6c754b6697d8c62381e38835
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-11T09:06:16Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-bee769db6c754b6697d8c62381e388352023-11-16T19:21:38ZengMDPI AGBiomolecules2218-273X2023-01-0113219110.3390/biom13020191Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline UptakeEisuke Muto0Toshio Okada1Tsuyoshi Yamanaka2Hiroyuki Uchino3Masato Inazu4Department of Anesthesiology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, JapanDepartment of Anesthesiology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, JapanDepartment of Molecular Preventive Medicine, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanDepartment of Anesthesiology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, JapanDepartment of Molecular Preventive Medicine, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, JapanAlzheimer’s disease (AD) is thought to be a series of neuroinflammatory diseases caused by abnormal deposits of amyloid-β (Aβ) and tau protein in the brain as part of its etiology. We focused on Aβ aggregation and M1 and M2 microglial polarity in microglia to search for novel therapeutic agents. It has been reported that the inhibition of choline uptake via choline transporter-like protein 1 (CTL1) in microglia preferentially induces M2 microglial polarity. However, the role of the choline transport system on the regulation of microglial M1/M2 polarity in AD is not fully understood. Licochalcones (Licos) A–E, flavonoids extracted from licorice, have been reported to have immunological anti-inflammatory effects, and Lico A inhibits Aβ aggregation. In this study, we compared the efficacy of five Licos, from Lico A to E, at inhibiting Aβ1-42 aggregation. Among the five Licos, Lico E was selected to investigate the relationship between the inhibition of choline uptake and microglial M1/M2 polarization using the immortalized mouse microglial cell line SIM-A9. We newly found that Lico E inhibited choline uptake and Aβ1-42 aggregation in SIM-A9 cells in a concentration-dependent manner, suggesting that the inhibitory effect of Lico E on choline uptake is mediated by CTL1. The mRNA expression of tumor necrosis factor (TNF-α), a marker of M1 microglia, was increased by Aβ1-42, and its effect was inhibited by choline deprivation and Lico E in a concentration-dependent manner. In contrast, the mRNA expression of arginase-1 (Arg-1), a marker of M2 microglia, was increased by IL-4, and its effect was enhanced by choline deprivation and Lico E. We found that Lico E has an inhibitory effect on Aβ aggregation and promotes polarity from M1 to M2 microglia via inhibition of the CTL1 function in microglia. Thus, Lico E may become a leading compound for a novel treatment of AD.https://www.mdpi.com/2218-273X/13/2/191licochalconemicrogliacholine transporterM1/M2 polarization
spellingShingle Eisuke Muto
Toshio Okada
Tsuyoshi Yamanaka
Hiroyuki Uchino
Masato Inazu
Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline Uptake
Biomolecules
licochalcone
microglia
choline transporter
M1/M2 polarization
title Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline Uptake
title_full Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline Uptake
title_fullStr Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline Uptake
title_full_unstemmed Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline Uptake
title_short Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline Uptake
title_sort licochalcone e a β amyloid aggregation inhibitor regulates microglial m1 m2 polarization via inhibition of ctl1 mediated choline uptake
topic licochalcone
microglia
choline transporter
M1/M2 polarization
url https://www.mdpi.com/2218-273X/13/2/191
work_keys_str_mv AT eisukemuto licochalconeeabamyloidaggregationinhibitorregulatesmicroglialm1m2polarizationviainhibitionofctl1mediatedcholineuptake
AT toshiookada licochalconeeabamyloidaggregationinhibitorregulatesmicroglialm1m2polarizationviainhibitionofctl1mediatedcholineuptake
AT tsuyoshiyamanaka licochalconeeabamyloidaggregationinhibitorregulatesmicroglialm1m2polarizationviainhibitionofctl1mediatedcholineuptake
AT hiroyukiuchino licochalconeeabamyloidaggregationinhibitorregulatesmicroglialm1m2polarizationviainhibitionofctl1mediatedcholineuptake
AT masatoinazu licochalconeeabamyloidaggregationinhibitorregulatesmicroglialm1m2polarizationviainhibitionofctl1mediatedcholineuptake